Tumor and immune compartments in radiation-targeted tumors with or without ICI were defined via PanCK and CD45 co-staining, respectively, with tumor-immune interface regions of interest (ROIs) segmented into tumor- and immune-enriched areas of interest (AOIs) (Fig. 2c, S2a-c). Here, PTPRC is linked to neoplasm.